Standout Papers

Lapatinib Combined With Letrozole Versus Letrozole and Placebo As First-Line Therapy for Postmen... 2009 2026 2014 2020 747
  1. Lapatinib Combined With Letrozole Versus Letrozole and Placebo As First-Line Therapy for Postmenopausal Hormone Receptor–Positive Metastatic Breast Cancer (2009)
    Stephen Johnston, John Pippen et al. Journal of Clinical Oncology

Immediate Impact

1 by Nobel laureates 5 from Science/Nature 76 standout
Sub-graph 1 of 20

Citing Papers

Fluorescent Probes for Disease Diagnosis
2024 Standout
Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones
2023 Standout
15 intermediate papers

Works of Saeed Sadeghi being referenced

Phase III Study of Doxorubicin/Cyclophosphamide With Concomitant Versus Sequential Docetaxel As Adjuvant Treatment in Patients With Human Epidermal Growth Factor Receptor 2–Normal, Node-Positive Breast Cancer: BCIRG-005 Trial
2011
Lapatinib Combined With Letrozole Versus Letrozole and Placebo As First-Line Therapy for Postmenopausal Hormone Receptor–Positive Metastatic Breast Cancer
2009 Standout

Author Peers

Author Last Decade Papers Cites
Saeed Sadeghi 1095 278 350 498 434 40 1.6k
Margaret M. Kozak 741 279 617 312 305 48 1.5k
Jinming Yu 1191 275 560 646 445 62 2.1k
Denis L. Jardim 1004 197 597 637 601 61 1.9k
Per‐Ebbe Jönsson 913 346 235 429 267 35 1.5k
Débora De Melo Gagliato 908 165 408 506 485 33 1.5k
M Francoual 1474 246 710 678 320 60 2.2k
Daniel L. Suzman 1237 258 343 777 239 56 1.9k
Scott Ernst 727 297 543 644 268 55 1.8k
Ernesto Wasserman 799 139 409 352 372 35 1.2k
Renata A. Coudry 607 185 581 548 428 37 1.4k

All Works

Loading papers...

Rankless by CCL
2026